While ER-positive breast tumors with low grade are considered to have a relative good prognosis in breast cancer [1], within these low-grade tumors, we observed that high levels of CD4 or CD8 were associated with poor outcome (log-rank test; p < 0.0001; Fig. 3g, h). The gene discussed is CD8A; the disease is breast cancer.